This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • External Eye Disease  • Alert me on articles by topic

Arch Ophthalmol. 2004;122:1714-1717.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Most lacrimal gland lesions are inflammatory or lymphoid neoplasms.¹ Nonlymphoid neoplasms are less common, and most are primarily epithelial in origin.^1-2 Among them, pleomorphic adenoma and adenoid cystic carcinoma are the most common benign and primary malignant tumors, respectively, accounting for 12% and 4% of all lacrimal gland lesions.² Epithelial-myoepithelial carcinoma is an exceptional malignant epithelial tumor in view of its rarity and the relative lack of understanding of its clinical behavior. These rare tumors usually occur in the salivary gland, and, to our knowledge, only 2 cases in the lacrimal gland have been reported. One of these was a hybrid carcinoma and the other was an epithelial-myoepithelial carcinoma with pleomorphic adenoma background.^1-5 We herein report a case of de novo epithelial-myoepithelial carcinoma of the lacrimal gland.

Report of a Case

An 80-year-old Chinese man had a painless, palpable subcutaneous mass in his left upper outer eyelid for 9 months. On examination, a contrast-enhancing . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION
Wai-Man Chan, MRCP, FRCS; David T. L. Liu, MRCS; Lawrence Y. M. Lam, FRCS; Paul C. L. Choi, FRCPA; Carmen K. M. Chan, MRCP, MRCOphth; Dennis S. C. Lam, MD, FRCS, FRCOphth; Nongnart R. Chan, MD